A MULTICENTER OPEN-LABEL STUDY OF ETANERCEPT WITHDRAWAL AND RETREATMENT IN SUBJECTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WHO ACHIEVED ADEQUATE 24 WEEK RESPONSE

Rheumatology - Axial Spondyloarthritis
Philip Mease, MD
Estimate the proportion of subjects who flare within 40 weeks following withdrawal of etanercept.

Inclusion Criteria:
Diagnosis of axial SpA duration of symptoms >3 months and <5 years back pain with a less than favorable response to NSAIDs

Exclusion Criteria:
Radiological sacroiliitis previous treatment with TNF inhibitor, biologic, immunosuppressive
Allison Everett
206-386-3201